The current valuation score of Dbv Technologies SA is 9.32, ranking 21 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -3.00, which is -26.28% below the recent high of -2.21 and -541.54% above the recent low of -19.24.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.